Does the military need more consistent and effective procedures for getting mild traumatic brain injury patients back to activity?

by U.S. Medicine

March 10, 2014
Please read this article and participate in this month’s online opinion poll.

Yes
No
Undecided

Current Results


Related Articles

Should the VA play a role in scheduling veterans’ appointments for outside care?

Please read this article and participate in this month’s online opinion poll: Should the VA play a role in scheduling veterans’ appointments for outside care? Yes No Not SureCurrent Results


U.S. Medicine Recommends


More From opinion

Opinion

Opinion Poll June: Does VA bureaucracy keep staff psychiatrists from providing the best care?

WASHINGTON — In the last decade, the development of multiple molecular-targeted therapies has dramatically altered the treatment landscape for advanced renal cell carcinoma (RCC). The rate of new drug approvals has outpaced the ability of... View Article

Opinion

Should the VA play a role in scheduling veterans' appointments for outside care?

WASHINGTON — In the last decade, the development of multiple molecular-targeted therapies has dramatically altered the treatment landscape for advanced renal cell carcinoma (RCC). The rate of new drug approvals has outpaced the ability of... View Article

Opinion

Do you think the VA pays enough to always attract high-quality physicians?

WASHINGTON — In the last decade, the development of multiple molecular-targeted therapies has dramatically altered the treatment landscape for advanced renal cell carcinoma (RCC). The rate of new drug approvals has outpaced the ability of... View Article

Opinion

Is VA doing enough to assert ownership rights of healthcare-related inventions made by employees using federal funds?

WASHINGTON — In the last decade, the development of multiple molecular-targeted therapies has dramatically altered the treatment landscape for advanced renal cell carcinoma (RCC). The rate of new drug approvals has outpaced the ability of... View Article

Opinion

Do proposed national guidelines on opioid prescriptions give enough consideration to chronic-pain patients?

WASHINGTON — In the last decade, the development of multiple molecular-targeted therapies has dramatically altered the treatment landscape for advanced renal cell carcinoma (RCC). The rate of new drug approvals has outpaced the ability of... View Article

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up